Dr. Reddy’s Lab loses patent case with Eli Lilly

25 Jun 2018 Evaluate

Dr. Reddy’s Laboratories has lost a legal battle with Eli Lilly and Company in a patent litigation on Alimta (pemetrexed for injection), a drug used for treatment of various types of cancer, in the USA. The US District Court for the Southern District of Indiana ruled in favor of Lilly.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1325.50 11.60 (0.88%)
11-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.90
Dr. Reddys Lab 1325.50
Cipla 1329.90
Zydus Lifesciences 922.00
Lupin 2345.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×